Breast implants recalled

27 September 2019

The Therapeutic Goods Administration (TGA) continues to review and assess breast implants available in the Australian market.

Allergan textured breast implants
Allergan textured breast implants
Source: © Australian Government Department of Health – Therapeutic Goods Administration

For more information and the latest updates, visit the TGA's breast implant hub (external site).

On 2 August 2019, the Allergan company voluntarily recalled (external link) their un-implanted Biocell macro-textured breast implants and tissue expanders due to a risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system. Another company also cancelled their product (Emergo Airxpanders Aeroform tissue expanders).

For more information, the TGA has a fact sheet about the Allergan recall (external link).

On 26 September 2019, the TGA published its decision to recall and suspend a number of other breast implants and tissue expanders.

The full list of recalled and suspended products can be found on the TGA’s breast implant hub (external site).

The TGA fact sheet states that if you have symptoms such as pain, swelling, a rash or a lump in your breast, armpit or elsewhere or you are not sure about changes in your breast, please discuss these with your general practitioner (GP), surgeon or other appropriate medical professional as soon as possible.

You can also call healthdirect on 1800 022 222 for further information.